codexis inc
(CDXS:Consolidated Issue Listed on Nasdaq Glbl Slct Mrkt)

Executive Profile*

Background*

Dr. William A. Haseltine, Ph.D., serves as the Chairman and Chief Executive Officer at Haseltine Associates Ltd. Dr. Haseltine has been Senior Advisor at Global Virus Network since May 2013. He serves as President of ACCESS Health International, Inc. He serves as Advisor of indiGENE Pharmaceuticals, Pvt. Ltd. He served as an Advisor at Frazier Healthcare Ventures. Dr. Haseltine founded seven biotechnology companies including Human Genome Sciences Inc., Verenium Corporation, ... Dendreon Corp., and Diversa Corp. He was a Senior Life Sciences Advisor at CMEA Capital untill 2008. Dr. Haseltine previously served as an Advisor at Healthcare Ventures when he participated in the creation of more than 20 other biotech firms, including Medimmune. He previously served as the Chairman and Chief Executive Officer at Human Genome Sciences Inc. and Member of its Executive Committee. He founded On-Q-ity Inc. in 2004 and served as its Chair of Board of Directors. Dr. Haseltine served as a Consultant from December 1992 until May 1993. He serves as Chairman of Advisory Board at Mylan Laboratories Limited. Dr. Haseltine served as a Director of Human Genome Sciences Inc. from 1993 to October 17, 2004 and its Chairman until October 17, 2004. He serves on the Board of Solena Group, Inc., Profectus Biosciences, Inc., and Council on Foreign Relations, Inc. He has been Special Advisor to the Board of Directors at Codexis, Inc. since June 2005. He served as Director of Consumer Health Services, Inc. He served as Member of the Board of Directors at Codexis, Inc. Dr. Haseltine served as the Chairman of the Board of Trustees of the National Health Museum, Member of The Brookings Institution Board of Trustees, and Member of The Trilateral Commission. He is a Member of the faculty of Harvard Medical School and the Dana Farber Cancer Institute, from 1976 to May 1993, a Member of the faculty of the Harvard School of Public Health, from 1977 to May 1993, and Chief of Human Retrovirology at the Dana Farber Cancer Institute, from 1988 to May 1993. Dr. Haseltine has a distinctive record of academic achievement in both cancer and AIDS research, for which he has received numerous awards and honors. Dr. Haseltine has also published more than 250 scientific papers and authored several books. He founded The Journal of AIDS Research and Retrovirology, and The Journal of Regenerative Medicine. Dr. Haseltine is Trustee and Director of The Alliance for Aging Research (AFAR), is on the Board of Trustees of the National Health Museum, Co-Chairman of the President's Council of Cold Spring Harbor Laboratories, serves on the Chief Executive Officer Council of the New York Academy of Sciences, is a member of the Global Business Council on HIV/AIDS Corporate Advisory Board, and is a member of the Board of Visitors of Johns Hopkins Medical School. Dr. Haseltine is also involved in Public and International Policy. He is a Member of the Board of Directors of the U.S. Chamber of Commerce, Trustee Board of the Brookings Institution, and the Chairman's Circle of the Asia Society. Dr. Haseltine also serves on the Boards of the Aspen Institute of Italy, the Business Executives for National Security, and is a member of The Council of Foreign Relations, as well as the Trilateral Commission. He served as a Director of Biotechnology Industry Organization. Dr. Haseltine is also a Professor at the Scripps Research Institute. He was was a professor at Harvard Medical School and Harvard School of Public Health, from 1976 to 1993. Dr. Haseltine holds an undergraduate degree in Chemistry from the University of California at Berkeley and a PhD in Biophysics from Harvard University. He did his post-graduate studies at the Massachusetts Institute of Technology with David Baltimore.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
CDXS:US	$2.38 USD	+0.02

COMPETITOR COMPENSATION